Cardiac events in Brugada syndrome (BS) 
Introduction
Brugada syndrome (BS) is a genetic disease characterized by a distinctive ECG pattern, associated with an elevated risk for sudden cardiac death (SCD) due to malignant ventricular arrhythmias [1] . Since major cardiac events commonly occur at rest and especially during sleep, the disease is tipically related to vagal activity malfunction [2] . Moreover, data on cardiac autonomic nervous system (ANS) analyzed by positron emission tomography has evidenced that these patients display a sympathetic autonomic dysfunction [3] . Thus, changes in the autonomic modulation captured by heart rate variability (HRV) analysis may provide valuable information for risk stratification. Indeed, previous studies have already analyzed the autonomic function in BS, but they are mostly based on longterm measurements leading to contradictory results [4] [5] [6] [7] .
The autonomic response can be better characterized by stimulating the ANS through standardized maneuvers such as the head-up tilt (HUT) test. This particular stimulation provokes a redistribution of blood volume to the lower part of the body, causing a reflex sympathetic activation and a vagal inhibition that induces an increase in heart rate [8] .
Although previous works have reported the role of HUT testing in BS [5, 6, 9 , 10], we are not aware of any study assessing the temporal progression of these patients' autonomic function under such conditions. Thus, the aim of this work was to analyze the autonomic response to HUT testing on 65 BS patients and compare, according to symptomatic status, the inter-patient temporal evolution of spectral HRV features resulting from time-frequency analysis.
Methodology

Study population
The standard 12-lead ECG recordings from 65 BS patients were collected during a HUT test divided in the following three phases: i) supine rest for 10 minutes, ii) tilting with an inclination of 60
• for 45 minutes and iii) rest in supine position for 10 minutes.
Patients were enrolled in 6 French university hospitals: Rennes, Saint Pierre de la Réunion, Nantes, Bordeaux, Brest and La Rochelle. After approval by the ethics committee of each center, all participants provided informed written consent to participate in the study.
Patients' age ranged from 19 to 79 years old (46.77 ± 12.57) and 80% were males. No significant differences in age and gender between symptomatic and asymptomatic groups were noted. Twenty patients had experienced the following symptoms: syncope (55%), cardiac arrest (35%), dizziness (15%), palpitations (10%) and nocturnal convulsions (5%). The remaining 45 patients were considered as asymptomatic.
Cardioverter defibrillator implantations (ICD) had been performed in 12 of 45 (26.67%) asymptomatic patients, based on a positive EPS test, whereas all symptomatic patients were ICD carriers. Genetic testing in search of SCN5A mutations was completed in 51 patients (18 were symptomatic) and among 17 subjects in whom the SCN5A mutation was found, 7 were symptomatic.
2.2.
Heart rate variability
From the ECG recordings of each patient, RR-interval and R-peak amplitude series were identified by a noiserobust wavelet-based algorithm for QRS complex detection and subsequent R-peak location [11] . A cubic splines interpolation was then applied to these signals in order to obtain uniformly sampled data at a rate of 4 Hz. To remove their very low frequency component, signals were high-pass filtered at 0.03 Hz with a 4 th order Butterworth filter applied in both forward and backward directions.
Given the non-stationarity of signals acquired during HUT testing, spectral HRV characteristics were analyzed by a time-frequency (TF) approach based on the Smoothed Pseudo Wigner-Ville distribution (SPWVD) transform, available from the Time-Frequency toolbox [12] .
This quadratic TF method is defined as the Fourier transform of the instantaneous autocorrelation function [13] , smoothed by the kernel function Ψ(τ, υ), defined in Costa et al [14] , that attenuates interferences while maintaining a suitable TF resolution. Being A RR (τ, υ) the Ambiguity Function of the RR series, x RR (t), the SPWVD is defined:
HRV was estimated as the total power in LF and HF bands (noted as LF b and HF b), extracted from the SP-WVD. Assuming that sympathetic activity always lies within the standard LF band, LF b was fixed between 0.04 and 0.15 Hz for the whole test. However, since the total power in the HF band should capture parasympathetic activity, closely related to respiration, and respiratory frequency during an ANS stimulation may not be restricted to the classic HF band (0.15 − 0.4 Hz), fixing HF b could lead to unreliable estimates of the vagal tone. To overcome this limitation, a time-varying HF band, based on an estimation of the respiration activity captured by the ECGDerived respiration (EDR) series was implemented [15] .
The estimated respiration signal was extracted from the amplitude modulation of R-wave peaks [16] , band-pass filtered by a 4 th order Butterworth filter between 0.15 and 0.7 Hz, applied in both forward and backward directions, so as to remove frequencies out of the respiratory range. The same SPWVD transform used for RR series was then applied to EDR filtered signals to obtain the instantaneous respiratory frequency.
As in [17] , this respiratory frequencyf (t) was estimated as that presenting the largest peak in the spectrum at each time instant. Moreover, in order to avoid spurious peak detections, for each time instant t k , the search interval was limited to frequencies between 2δ Hz, centered around a reference frequency f r (t k ) : [f r (t k ) − δ, f r (t k ) + δ], defined as the exponential average of previous estimates:
where β was the forgetting factor. To reduce the risk of spurious frequency detections in the initialization of f r (t), the first instantaneous respiratory frequency f r (t 0 ) was selected within the standard HF band (0.15 − 0.4 Hz). Once f r (t) was estimated, the time-varying HF band was defined as HF b(t) = [f r (t) − 0.125, f r (t) + 0.125] Hz, with t covering the whole test. The obtained time series accounting for the sympathetic and parasympathetic influences of the ANS on heart rate were normalized by the total power, defined as the sum of both spectral bands (T P (t) = LF (t)+HF (t)), leading to the time series LF nu (t) and HF nu (t). From this definition of normalization, it should be noted that statistical results for both LF nu (t) and HF nu (t) series are identical. LF HF (t) was also calculated from dividing LF (t) by HF (t), so as to obtain the time-varying global sympathovagal balance.
Then, these HRV time series were averaged for the whole baseline period (B), in supine rest before tilting.
After subtracting these reference values from each time series, they were averaged in temporal nonoverlapped windows of 1 minute, leading to ΔLF i nu , ΔHF i nu and ΔLF/HF i , which stand for the time series' intra-patient mean for the following time periods: i ∈ {T 1, T 2, · · · , T 45, S1, S2, · · · , S10}. T refers to the tilting phase, while S accounts for the supine rest after tilting period. Fig 1 illustrates those phases composing the HUT test, as well as some of the analyzed 1-min segments. The extracted HRV features were finally compared between symptomatic and asymptomatic groups, by MannWhitney U non-parametric tests.
3.
Results Figure 2 represents the mean ΔHF nu and the mean ΔLF/HF for both groups of patients, highlighting those 1-min segments where differences between symptomatic and asymptomatic patients were significant. It should be noted that, since the baseline value was subtracted for each patient, time series are represented in relative units (r.u.).
During tilting, ΔHF nu decreased with respect to baseline for both groups. However, symptomatic patients presented higher ΔHF nu values. Although this difference was statistically significant at different time periods, the largest segment was found before the 15 th minute in upright posture (ΔHF T 11 nu : p = 0.030; ΔHF T 12 nu : p = 0.031; ΔHF T 13 nu : p = 0.010; ΔHF T 15 nu : p = 0.022). After tilting, HF nu was similarly restored to baseline values for both symptomatic and asymptomatic patients.
Conversely, ΔLF/HF increased with respect to baseline in both groups during tilting, being asymptomatic patients those presenting the highest values. Statistically significant differences between groups in ΔLF/HF were found in similar time periods than for ΔHF nu , including the segment before the 15 th minute in upright posture (ΔLF/HF T 13 : p = 0.034; ΔLF/HF T 15 : p = 0.014). Moreover, after tilting, asymptomatic patients reached baseline LF/HF values more rapidly, leading to significant differences between groups during the third minute in post-tilt supine rest (ΔLF/HF S3 : p = 0.047).
Conclusion
The time-varying autonomic response to a standardized HUT test was assessed in 65 BS patients. According to the results, with respect to baseline, an increased parasympathetic tone (ΔHF nu ) and a reduced sympathovagal balance (ΔLF/HF ) were observed in symptomatic patients during tilting, in comparison to asymptomatic subjects. Some significant differences were captured by both autonomic markers around the 35 th minute of tilting and, by the sympathovagal balance, during the third minute in supine rest after tilting, suggesting that sympathovagal balance was more rapidly restored to baseline values in asymptomatic patients. Nevertheless, since the largest and most significant segment was found before the 15 th minute in upright posture, the results suggest the potential of employing time-reduced HUT testing for risk stratification in BS. Indeed, a previous work from our team already reported the potential of 15-min HUT tests for early syncope detection [18] .
Furthermore, the results confirm previous findings where symptomatic BS patients showed higher vagal [4, 5, 7] and reduced sympathetic [7] tones with respect to asymptomatic patients, supporting the idea that decreased sympathetic and increased vagal responses could be related to a worse prognosis in BS.
Although comparisons are based on the symptomatic status of a relatively small population of BS patients and, thus, conclusions on the prediction of cardiac events cannot be inferred, the results indicate important trends of clinical relevance with a potential impact on the identification of BS patients at high risk. 
